NIRVF (Nirvana Life Sciences) Unearned Premiums

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Nirvana Life Sciences Unearned Premiums?

Unearned Premiums only applies to insurance companies.

Nirvana Life Sciences Business Description

Other Exchanges NIRV.X:Canada
Address 650 West Georgia Street, Suite 2110, Vancouver, BC, CAN, V6B 4N8
Nirvana Life Sciences Inc. is a Canadian life sciences company focused on research and development of therapeutic products derived from psychedelic compounds. It works on novel formulations of psilocybin and other naturally sourced psychedelics, targeting indications such as chronic pain, opioid dependency, and other health conditions. The company also develops methodologies for standardized, quality-controlled extraction and purification of psychoactive compounds, aiming to support consistent dosing and regulatory compliance. It operates in a single reportable segment, the research and development of psychedelic-derived therapeutics, and is based in Canada. As a development-stage enterprise, it does not yet generate meaningful product revenue; its activities are funded through equity financing and similar sources while it advances preclinical research and formulation work. Its primary stakeholders are investors and research collaborators rather than commercial customers.